Therapeutics in radiation-induced proctopathy: a systematic review
J. coloproctol. (Rio J., Impr.); 42 (1), 2022
Malignant neoplasms are increasingly prevalent in the daily clinical practice. Up to 61% of patients with pelvic malignancies undergo pelvic radiotherapy in different doses, which may cause intestinal damage, and the rectum is the segment most frequently affected due to its fixed position in the pelvis. ...